These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19506428)

  • 1. Why are some Parkinson disease patients unaware of their dyskinesias?
    Jenkinson PM; Edelstyn NM; Stephens R; Ellis SJ
    Cogn Behav Neurol; 2009 Jun; 22(2):117-21. PubMed ID: 19506428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor self-awareness of levodopa-induced dyskinesias in Parkinson's disease: clinical features and mechanisms.
    Pietracupa S; Fasano A; Fabbrini G; Sarchioto M; Bloise M; Latorre A; Altieri M; Bologna M; Berardelli A
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1004-8. PubMed ID: 23890762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks.
    Liu X; Carroll CB; Wang SY; Zajicek J; Bain PG
    J Neurosci Methods; 2005 May; 144(1):47-52. PubMed ID: 15848238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990.
    Van Gerpen JA; Kumar N; Bower JH; Weigand S; Ahlskog JE
    Arch Neurol; 2006 Feb; 63(2):205-9. PubMed ID: 16476808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neither simple nor sequential arm movements are bradykinetic in parkinsonian patients with peak-dose dyskinesias.
    Agostino R; Bagnato S; Dinapoli L; Modugno N; Berardelli A
    Clin Neurophysiol; 2005 Sep; 116(9):2077-82. PubMed ID: 16055379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Movement patterns of peak-dose levodopa-induced dyskinesias in patients with Parkinson's disease.
    Gour J; Edwards R; Lemieux S; Ghassemi M; Jog M; Duval C
    Brain Res Bull; 2007 Sep; 74(1-3):66-74. PubMed ID: 17683791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinesia in patients with Parkinson's disease having levodopa-induced dyskinesias.
    Ghassemi M; Lemieux S; Jog M; Edwards R; Duval C
    Brain Res Bull; 2006 May; 69(5):512-8. PubMed ID: 16647580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired awareness of movement disorders in Parkinson's disease.
    Amanzio M; Monteverdi S; Giordano A; Soliveri P; Filippi P; Geminiani G
    Brain Cogn; 2010 Apr; 72(3):337-46. PubMed ID: 19914762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa-induced dyskinesias detection based on the complexity of involuntary movements.
    Chelaru MI; Duval C; Jog M
    J Neurosci Methods; 2010 Jan; 186(1):81-9. PubMed ID: 19878692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
    Fenney A; Jog MS; Duval C
    Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease.
    Filipović SR; Rothwell JC; van de Warrenburg BP; Bhatia K
    Mov Disord; 2009 Jan; 24(2):246-53. PubMed ID: 18951540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imagining the impossible: motor representations in anosognosia for hemiplegia.
    Jenkinson PM; Edelstyn NM; Ellis SJ
    Neuropsychologia; 2009 Jan; 47(2):481-8. PubMed ID: 18973767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
    Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
    J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-unawareness of levodopa induced dyskinesias in patients with Parkinson's disease.
    Amanzio M; Palermo S; Zibetti M; Leotta D; Rosato R; Geminiani G; Lopiano L
    Brain Cogn; 2014 Oct; 90():135-41. PubMed ID: 25058494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
    Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
    Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities.
    Jenner P
    Mov Disord; 2008; 23 Suppl 3():S585-98. PubMed ID: 18781676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of motor intention in motor awareness: an experimental study on anosognosia for hemiplegia.
    Fotopoulou A; Tsakiris M; Haggard P; Vagopoulou A; Rudd A; Kopelman M
    Brain; 2008 Dec; 131(Pt 12):3432-42. PubMed ID: 18812442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-awareness of deficits in Parkinson disease.
    Leritz E; Loftis C; Crucian G; Friedman W; Bowers D
    Clin Neuropsychol; 2004 Aug; 18(3):352-61. PubMed ID: 15739807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesia.
    Lyons KE; Pahwa R
    Clin Neuropharmacol; 2006; 29(3):148-53. PubMed ID: 16772814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Self-awareness of deficits in Huntington's and Parkinson's disease].
    Sitek EJ; Sławek J; Wieczorek D
    Psychiatr Pol; 2008; 42(3):393-403. PubMed ID: 19899567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.